UPDATE: BMO Capital Downgrades CytomX Therapeutics (CTMX) to Market Perform
Tweet Send to a Friend
(Updated - November 14, 2022 6:28 AM EST)
BMO Capital analyst Etzer Darout downgraded CytomX Therapeutics (NASDAQ: CTMX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Etzer Darout downgraded CytomX Therapeutics (NASDAQ: CTMX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
